Catalent plans to invest an estimated $45 million to expand its facilities and purchase new equipment for its production ...

Catalent Pharma Solutions' latest expansion in Madison is bringing a boost to Wisconsin’s growing biohealth sector, with a ...

Catalent will invest $45 million to expand in Madison, supporting the state’s growth as a federal biohealth tech hub.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Novo Holdings' $16.5bn takeover of US CDMO Catalent has been completed, after months of debate over potential antitrust issues.

Eli Lilly has called on financial regulators to examine the antitrust implications of Novo Holdings' purchase of Catalent and sale of three manufacturing plants to Novo Nordisk.

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

ROME (Reuters) -Italian authorities on Monday appointed a special commissioner to help Danish drugmaker Novo Nordisk speedily ...

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 ...

The Danish investment company Novo Nordisk A/S has received approval from the US Federal Trade Commission (FTC) to acquire the production assets of Catalent Inc., one of the world's largest ...

The budget committee voted 13-3 with Sen. LaTonya Johnson (D-Milwaukee) joining Republicans in favor of approving the ...